Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
Clinical trial NCT05397470 · TERMINATED
Trial details
- NCT number
- NCT05397470
- Sponsor
- Fulcrum Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-16
- Primary completion
- 2024-11-19
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.